Immunogenicity of an Eight Amino Acid Domain Shared by Fas (CD95/Apo-I) and HIV-1 gp120. I. Structural and Antigenic Analysis

Molecular Medicine

Volumn 6, Issue 6, 2000, Pages 494-508

  Silvestris, Franco ^a   Cocco, Tiziana ^b   Cafforio, Paola ^a   Calvani, Nicola ^a   Dammacco, Franco ^a  

^a Section of Internal Medicine and Clinical Oncology   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Adjacent Peptide; High Immunogenicity; sFas Levels

Indexed keywords

EPITOPE; FAS ANTIGEN; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MOLECULAR GENETICS; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANTIGENS, CD95; APOPTOSIS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID;

MLCS; MLOWN;

EID: 0034200951     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03401790     Document Type: Article

References (46)

1. L.A. Barnett R.S. Fujinami Molecular mimicry: a mechanism for autoimmune injury FASEB J. 1992 6 840 844 10.1096/fasebj.6.3.1740233 1:CAS:528:DyaK38XhsV2muro%3D 1740233
2. A.E. Karlsen T. Dyrberg Molecular mimicry between non-self, modified self and self in autoimmunity Semin. Immunol. 1998 10 25 34 10.1006/smim.1997.0102 1:CAS:528:DyaK1cXisFGqsr0%3D 9529653
3. C. Süsal M. Kröpelin V. Daniel G. Opelz Molecular mimicry between HIV-1 and antigen receptor molecules. A clue to the pathogenesis of AIDS Vox Sang. 1993 65 10 17 10.1111/j.1423-0410.1993.tb04518.x 8103248
4. L. Lopalco C. Desantis R. Meneveri et al. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I α 1 peptide-binding domain Eur. J. Immunol. 1993 23 2016 2021 10.1002/eji.1830230844 1:CAS:528:DyaK3sXmtVWlsLw%3D 8344367
5. F. Silvestris R.C. Williams F. Dammacco Autoreactivity in HIV-1 infection: the role of molecular mimicry Clin. Immunol. Immunopathol. 1995 75 197 205 10.1006/clin.1995.1072 1:STN:280:DyaK2M3osFKjtQ%3D%3D 7768037
6. F. Silvestris S. Nagata P. Cafforio N. Silvestris F. Dammacco Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1-infected patients J. Exp. Med. 1996 184 2287 2300 10.1084/jem.184.6.2287 1:CAS:528:DyaK2sXjt1Sn 8976184 2196362
7. N. Itoh S. Yonehara A. Ishii et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 1991 66 233 243 10.1016/0092-8674(91)90614-5 1:CAS:528:DyaK38XksVWls7Y%3D 1713127
8. J. Dhein P.T. Daniel B.C. Trauth A. Oehm P. Möller P.H. Krammer Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigen J. Immunol. 1992 149 3166 3173 1431095 1:CAS:528:DyaK3sXnvV2nug%3D%3D
9. F. Silvestris P. Cafforio A. Romito F. Dammacco Molecular specificities of CD4+ T cell reactive IgG and IgM in human immunodeficiency virus (HIV) infection Clin. Immunol. Immunopathol. 1994 70 40 46 10.1006/clin.1994.1008 1:CAS:528:DyaK2cXisVagsb0%3D 7903230
10. P.W. Szawlowski T. Hanke R.E. Randall Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas AIDS 1993 7 1018 1019 10.1097/00002030-199307000-00019 1:STN:280:DyaK3szmtlantg%3D%3D 7689322
11. I.M. Antonioli C. Baumberger S. Yerly L. Perrin V3 sequences in primary HIV-1 infection AIDS 1995 9 11 17 10.1097/00002030-199501000-00002 1:CAS:528:DyaK2MXktFKksLw%3D 7893436
12. T. Vogel R. Kurth S. Norley The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1 MN multiple antigenic peptides J. Immunol. 1994 153 1895 1904 7519220 1:CAS:528:DyaK2cXmsFehsL4%3D
13. T. Suda S. Nagata Purification and characterization of the Fas-ligand that induces apoptosis J. Exp. Med. 1994 179 873 879 10.1084/jem.179.3.873 1:CAS:528:DyaK2cXhs1WlsrY%3D 7509364
14. M. Tanaka T. Suda T. Takahashi S. Nagata Expression of the functional soluble form of human Fas ligand in activated lymphocytes EMBO J. 1995 14 1129 1135 7536672 398190 1:CAS:528:DyaK2MXlsFSnsr8%3D 10.1002/j.1460-2075.1995.tb07096.x
15. K. Stricker E. Knipping T. Böhler A. Benner P.H. Krammer K.-M. Debatin Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children Cell Death Differ. 1998 5 222 230 10.1038/sj.cdd.4400332 1:CAS:528:DyaK1cXisV2hu70%3D 10200468
16. F. Silvestris O. Cafforio M.A. Frassanito et al. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis AIDS 1996 10 131 141 10.1097/00002030-199602000-00002 1:STN:280:DyaK28vjsFyitg%3D%3D 8838700
17. P.D. Katsikis E.S. Wunderlich C.A. Smith L.A. Herzenberg L.A. Herzenberg Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus infected individuals J. Exp. Med. 1995 181 2029 2036 10.1084/jem.181.6.2029 1:CAS:528:DyaK2MXlvFSjtL4%3D 7539037
18. R. Gehri S. Hahn M. Rothen M. Steverwald R. Nuesch P. Erb The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells AIDS 1996 10 9 16 10.1097/00002030-199601000-00002 1:STN:280:DyaK283mtlKkug%3D%3D 8924258
19. C. Bäumler I. Herr T. Böhler A. Benner P.H. Krammer K.-M. Debatin Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1 infected children Blood 1996 88 1741 1746 8781430
20. N.K. Prasad G. Papoff A. Zeuner et al. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway J. Immunol. 1998 161 3781 3790 9759905 1:CAS:528:DyaK1cXmsFahtL0%3D
21. E. Knipping P.H. Krammer K.B. Onel T.J.A. Lehman E. Mysler K.B. Elkon Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis Arthritis Rheum. 1995 38 1735 1737 10.1002/art.1780381205 1:STN:280:DyaK287htVKktA%3D%3D 8849344
22. K. Nozawa N. Kayagaki Y. Tokano H. Yagita K. Okumura H. Hasimoto Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases Arthritis Rheum. 1997 40 1126 1129 10.1002/art.1780400617 1:CAS:528:DyaK2sXktV2qt7w%3D 9182923
23. N. Susuki M. Ichino S. Mihara S. Kaneko T. Sakane Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus Arthritis Rheum. 1998 41 344 353 10.1002/1529-0131(199802)41:2<344::AID-ART19>3.0.CO;2-J
24. T. Suda H. Hashimoto M. Tanaka T. Ochi S. Nagata Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing J. Exp. Med. 1997 186 2045 2050 10.1084/jem.186.12.2045 1:CAS:528:DyaK2sXotVGhsLs%3D 9396774 2199173
25. B. Fadeel A. Samuelsson T. Hachiya C. Broström F. Chiodi Elevated serum levels of soluble Fas/APO-1 in human immunodeficiency virus-infected individuals Blood 1996 89 4727 4730
26. N. Hosaka N. Oyazu M.H. Kaplan H. Yagita S. Pahwa Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons J. Infect. Dis. 1998 178 1030 1039 10.1086/515700 1:CAS:528:DyaK1cXmvVWkt70%3D 9806031
27. Center for Disease Control and Prevention 1992 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults Morb. Mortal. Wkly. Rep. 1993 41/RR-17 1 19
28. H.J. Geerligs W.J. Weijer W. Bloemhoff G.W. Welling S. Welling-Wester The influence of pH and ionic strength on the coating of peptides of herpes virus type 1 in an enzyme-linked immunosorbent assay J. Immunol. Methods 1988 106 239 244 10.1016/0022-1759(88)90203-7 1:CAS:528:DyaL1cXhtFSns7w%3D 2828477
29. F. Silvestris W. Anderson J.S. Goodwin R.C. Williams Discrepancy in the expression of autoantibodies in healthy aged individuals Clin. Immunol. Immunopathol. 1985 35 234 241 10.1016/0090-1229(85)90069-8 1:STN:280:DyaL28%2FotVahsA%3D%3D 3878247
30. B. Fadeel C.J. Thorpe S. Yonehara F. Chiodi Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro Int. Immunol. 1997 9 201 209 10.1093/intimm/9.2.201 1:CAS:528:DyaK2sXhs1yksrg%3D 9040002
31. D.C. Feller V.F. de la Cruz Identifying antigenic T-cell sites Nature 1991 349 720 721 10.1038/349720a0 1:STN:280:DyaK3M7ktFGrtQ%3D%3D 1705016
32. Y. Altuvia A. Sette J. Sidney S. Southwood H. Margalit A structure-based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets Hum. Immunol. 1997 58 1 11 10.1016/S0198-8859(97)00210-3 1:CAS:528:DyaK1cXksFKmtg%3D%3D 9438204
33. A. Sette S. Buus E. Appella et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis Proc. Natl. Acad. Sci. U.S.A. 1989 86 3296 3300 10.1073/pnas.86.9.3296 1:CAS:528:DyaL1MXit12lu7o%3D 2717617 287118
34. B. Huang M. Eberstadt E.T. Olejniczak R.P. Meadows S.W. Fesik NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain Nature 1996 384 638 641 10.1038/384638a0 1:CAS:528:DyaK2sXlsVaq 8967952
35. J.M.R. Parker D. Guo R.S. Hodges New hydrophilicity scale derived from high performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites Biochemistry 1986 25 5425 5432 10.1021/bi00367a013 1:CAS:528:DyaL28XlsFWjtb4%3D 2430611
36. D.W. Banner A. D’Arcy W. Janes et al. Crystal structure of the soluble human 55kd TNF receptor-human TNF-β complex: implications for TNF receptor activation Cell 1993 73 431 437 10.1016/0092-8674(93)90132-A 1:CAS:528:DyaK3sXkt1KnsLc%3D 8387891
37. M. Sutcliffe I. Haneef D. Carney T. Blundell Knowledge based modeling of homologous proteins. 1. Three-dimensional frameworks derived from the simultaneous superposition of multiple structures Protein Eng. 1987 1 377 385 10.1093/protein/1.5.377 1:CAS:528:DyaL1cXht1Ojs7w%3D 3508286
38. P.N. Nehete K.S. Casement R.B. Arlinghaus K.J. Sastry Studies on in vivo induction of HIV-1 envelope—specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1IIIB gp120 Cell. Immunol. 1995 160 217 223 10.1016/0008-8749(95)80031-D 1:CAS:528:DyaK2MXjs1Kgurc%3D 7720083
39. Z. Moukrim A. Achour Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals Cell Mol. Biol. 1995 41 439 444 7580839 1:CAS:528:DyaK2MXlvVGiu7c%3D
40. G.C. Starling J. Bajorath J. Emswiler J.A. Ledberter A. Aruffo P.A. Kiener Identification of amino acid residues important for ligand binding to Fas J. Exp. Med. 1997 185 1487 1492 10.1084/jem.185.8.1487 1:CAS:528:DyaK2sXjtFensbg%3D 9126929 2196280
41. B. Fadeel J. Lindberg A. Achour F. Chiodi A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites Int. Immunol. 1998 10 131 140 10.1093/intimm/10.2.131 1:CAS:528:DyaK1cXhslOjt74%3D 9533440
42. H.H. Euler P. Kern H. Loeffler M. Dietrich Precipitable immune-complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome Clin. Exp. Immunol. 1985 59 267 272 3156700 1577123 1:STN:280:DyaL2M7lt1KhsA%3D%3D
43. N.K. Banda J. Bernier D.K. Kurahara et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis J. Exp. Med. 1992 176 1099 1106 10.1084/jem.176.4.1099 1:CAS:528:DyaK38Xls12gsb0%3D 1402655
44. E. Aceituno S. Costanon C. Jimenez D. Subira M. De Gorgolas M. Fernandez-Guerrero Circulating immune complexes from HIV-1+ patients induces apoptosis on normal lymphocytes Immunology 1997 92 317 320 10.1046/j.1365-2567.1997.00361.x 1:CAS:528:DyaK2sXntlCrt7s%3D 9486102 1363790
45. B. Heilig C. Fiehn M. Brochaus H. Gallati A. Pezzuto W. Hunstein Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease J. Clin Immunol. 1993 13 321 328 10.1007/BF00920240 1:CAS:528:DyaK2cXhtVCktbg%3D 8245178
46. B. Tchernychev S. Cabilly M. Wilchet The epitopes for natural polyreactive antibodies are rich in proline Proc Natl. Acad. Sci. U.S.A. 1997 94 6335 6339 10.1073/pnas.94.12.6335 1:CAS:528:DyaK2sXjvFCksb8%3D 9177218 21050